David A Rozenson
@Essex Investment Management Co Llc
Latest period2024 - Q3ReportedManaged Assets$573.676MTotal holdings302
Assets growth rate7.29%Assets growth rate (2-Q avg)6.41%Continuous growth in asset value2 quarters
Portfolio positions
This chart displays the top 10 holdings in Essex Investment Management Co Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 302 positions.
Assets under management
The assets under management (AUM) of Essex Investment Management Co Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 573.676M in assets, with a quarterly growth rate of 7.29% and a 2-quarter average growth rate of 6.41%. The portfolio is managed by David A Rozenson, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
PFEPfizer Inc
| 0.77% | $4.37M 150,992 shares@ $28.94 avg price | New Position |
TARSTarsus Pharmaceuticals Inc
| 0.63% | $3.59M 109,156 shares@ $32.9 avg price | New Position |
BPMCBlueprint Medicines Corp
| 0.58% | $3.28M 35,461 shares@ $92.51 avg price | New Position |
LGTYAmer Software Inc
| 0.52% | $2.98M 266,295 shares@ $11.19 avg price | New Position |
ACVAAcv Auctions Inc
| 0.51% | $2.915M 143,368 shares@ $20.33 avg price | New Position |
LQDTLiquidity Svcs Inc
| 0.48% | $2.749M 120,587 shares@ $22.81 avg price | New Position |
PEGAPegasystems Inc
| 0.46% | $2.638M 36,091 shares@ $73.09 avg price | New Position |
DAWNDay One Biopharmaceuticals Inc
| 0.45% | $2.566M 184,230 shares@ $13.94 avg price | New Position |
AIPArteris Inc
| 0.44% | $2.504M 324,291 shares@ $7.73 avg price | New Position |
RCELAvita Medical Inc
| 0.44% | $2.477M 231,094 shares@ $10.73 avg price | New Position |